23. May 2023
Thank you for having us at the BosomShield kick off meeting. BosomShield is a project aiming a computer-aided design system for breast cancer classification and prognosis of relapse.
If you want to know further information about this project, visit bosomshield.eu.
International Clinical Trials Day
20. May 2023
Did you know that today is world clinical trials day? And did you know that mediri is working constantly to improve standardization of Arterial Spin Labeling MR Imaging for clinical trials? In the ASPIRE project (aspire-mri.eu) we are developing a web platform for easy and manufacturer independent analysis of ASL images for dementia diagnosis.
Want know more about this topic? Join us on ISMRM 2023 in Toronto and come to the ASL Dinner which is hosted by mediri GmbH and Gold Standard Phantoms.
MRI assessment of cerebral perfusion in clinical trials
16. May 2023
Have you ever thought about assessing cerebral perfusion non-invasively in your next clinical trial? If so, this recently published review paper will address the most important questions such as how to equalize data acquisition across sites, how to perform QC and process the data.
Read more here: https://lnkd.in/gE3Z8BKT
Consensus paper on current state of ASL MRI in clinical neuroimaging
03. May 2023
The implementation of ASL MRI for disease specific clinical cases has taken another milestone. Early 2023, a position paper supported by the ISMRM Perfusion Study Group updated and expanded the ASL MRI consensus paper from 2015 and provides guidance on using ASL MRI for clinical scenarios such as acute ischemic stroke, brain tumors and neurodegenerative diseases.
Click here to read: https://lnkd.in/dvd7BCCv
Consensus paper on recommended implementation of ASL MRI
24. April 2023
ASL perfusion MRI permits non-invasive quantification of cerebral blood flow. The 2015 consensus paper on recommended implementation of ASL MRI established general guidelines for more comparable data acquisition and reproducible research. Mediri is happy to be part of this exciting journey.
Read more here: https://lnkd.in/eFXeQmi2
We are a BVMA member
18. April 2023
After a successful member audit we are excited to be a part of the Bundesverband Medizinischer Auftragsinstitute e.V. (BVMA). We are looking forward to our first general meeting in Cologne and the networking opportunities.
Want to know more about BVMA? Click here: https://www.bvma.de/
h_da joins ASPIRE
28. March 2023
We proudly announce that the ASPIRE team has a new member: Darmstadt University of Applied Sciences joins the consortium and brings in expertise for AI-based brain image analysis and atlas creation. Together we will establish a platform independent dementia diagnosis support based on arterial spin labeling images.
mTRIAL 3.4. release
21. March 2023
We proudly announce the release of our new mTRIAL version. For the first time it incorporates a webbased comprehensive DICOM image viewer for platform independent and real time access of clinical trial data. Central read workflow planning and execution has been upgraded for even more reliable and efficient review of radiological data. mTRIAL 3.4. – ready to support your next image based clinical trial.
14. March 2023
We are very happy to welcome our new team member Yaqeen Ali. He joined mediri for his PhD as Marie Skłodowska-Curie-Fellow. He has completed his master’s degree in Computer Science at Comsats University Islamabad, Pakistan. Together with 9 other Phd students all over Europe he will work in the BosomShield Project aiming at a CAD system for breast cancer relapse prediction. Yaqeen will develop a prototype for a secure remote solution with web access for patient-individual multi-modal image analysis using cloud computing and federated learning.
Looking very much forward to this exciting project with Universitat Rovira i Virgili, KTH Royal Institute of Technology Radboudumc, Institut d’Investigació Sanitària Pere Virgili – IISPV, Nalecz Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences, University of Udine, UBFC – Université Bourgogne-Franche-Comté, Univerza v Mariboru and nVision Systems.
Digital Innovator Award 2023
13. March 2023
We proudly announce that mediri has been awarded as Digital Innovator 2023 in the category „medical technology and pharmaceuticals“ by CHIP. In times of digitization, CHIP and data analysis specialist Globis Consulting have studied the innovative power of German companies and institutes in digitization. CHIP is known as one oft the top recommendation brands.
See the full ranking here.